BioInvent receives EMA support for BI-1808
18 november, 17:04
18 november, 17:04
BioInvent has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) regarding orphan drug designation for BI-1808 in cutaneous T-cell lymphoma. According to CEO Martin Welschof, this step – together with the encouraging clinical data generated to date – reinforces the company’s commitment to advancing BI-1808 as a novel immunotherapy for CTCL patients.
Read the article at biostock.se:
BioInvent receives EMA support for BI-1808
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
18 november, 17:04
BioInvent has received a positive opinion from the European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) regarding orphan drug designation for BI-1808 in cutaneous T-cell lymphoma. According to CEO Martin Welschof, this step – together with the encouraging clinical data generated to date – reinforces the company’s commitment to advancing BI-1808 as a novel immunotherapy for CTCL patients.
Read the article at biostock.se:
BioInvent receives EMA support for BI-1808
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
Analyser
SBB
Inflationen
Federal Reserve
Analyser
SBB
Inflationen
Federal Reserve
Stockholmsbörsen
Igår, 17:57
H&M och Volvo steg på grön börs
EQT
Igår, 17:54
EQT säljer 16% av aktierna i nischbanken
EU
Igår, 16:53
EU godkänner Sveriges sociala klimatplan
OMX Stockholm 30
1 DAG %
Senast
2 829,04
